Cookies

Our site uses cookies to optimize the content and improve the performance. If you continue the browsing it will be considered that you accept that our webpage may be able to use your cookie files. For more information, please visit the "Privacy Policy" Privacy statement

Customize

Analytics Collect statistics data
Goal _ga, _gat, _gid, _gali
Methotrexate
Methotrexate
SDSDownload

Methotrexate / 1 G

Synonym: MTX; Trexall; Mexate; Antifolan; Rheumatrex; Ledertrexate; Methotrexate; (+)-Amethopterin; Methylaminopterin; Methylaminopterinum; 4-Amino-10-methylfolic acid; 4-Amino-N10-methylpteroyl-L-glutamic acid
Molecular Formula: C20H22N8O5
Molecular Weight: 454.44
SKU: MND-12292
CAS Number: 59-05-2
MDL number: MFCD00064370
EC Number: 200-413-8
Form: powder
Note: Prices are for comparison only. Contact Sales for current pricing.
Packing size: 1 G  
92.40 EUR


Safety Information


Hazard Statements

H225
H301 + H311 + H331
H370
H315
H319
H301
H360D
H341
H290

Precautionary Statements

P210
P280
P301 + P310
P303 + P361 + P353
P304 + P340 + P311
P305 + P351 + P338
P233
P302 + P352
P201
P301 + P310 + P330

Pictograms


Properties

Signal WordDanger

 Product Description

Methotrexate is a chemotherapy drug and immune system suppressant used to treat cancer, autoimmune diseases, and ectopic pregnancies. It works by inhibiting the growth of certain cells in the body.

 

Application:

Methotrexate is commonly prescribed for the treatment of various cancers such as leukemia, lymphoma, and breast cancer. It is also used to manage autoimmune conditions like rheumatoid arthritis and psoriasis.

 

 

Articles:

- Teratogen update: Methotrexate

Publication Date: 20 March 2012

Sara C. Hyoun, Sarah G. Običan, Anthony R. Scialli

https://doi.org/10.1002/bdra.23003

 

- THE MECHANISM OF ACTION OF METHOTREXATE

Publication Date: Available online 24 June 2005

Bruce N. Cronstein

https://doi.org/10.1016/S0889-857X(05)70358-6

 

- Methotrexate mechanism in treatment of rheumatoid arthritis

Publication Date: Available online 3 August 2018

Benjamin Friedman, Bruce Cronstein

https://doi.org/10.1016/j.jbspin.2018.07.004